Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 7

Results: 18

Targeting HER2/ neu with a fully human IgE to harness the allergic reaction against cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 991, doi. 10.1007/s00262-011-1150-z

By:

Daniels, Tracy;
Leuchter, Richard;
Quintero, Rafaela;
Helguera, Gustavo;
Rodríguez, José;
Martínez-Maza, Otoniel;
Schultes, Birgit;
Nicodemus, Christopher;
Penichet, Manuel

Publication type:

Article

Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 979, doi. 10.1007/s00262-011-1166-4

By:

Lai, Dongmei;
Wang, Fangyuan;
Chen, Yifei;
Wang, Chunhui;
Liu, Sha;
Lu, Bufeng;
Ge, Xirui;
Guo, Lihe

Publication type:

Article

Exploiting antitumor immunity to overcome relapse and improve remission duration.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1113, doi. 10.1007/s00262-011-1185-1

By:

Chen, Lei;
Chen, Xinjian;
Choi, Haesun;
Sang, Hongxun;
Chen, Leo;
Zhang, Hongbo;
Gouw, Launce;
Andtbacka, Robert;
Chan, Benjamin;
Rodesch, Christopher;
Jimenez, Arnie;
Cano, Pedro;
Jones, Kimberly;
Oyedeji, Caroline;
Martins, Tom;
Hill, Harry;
Schumacher, Jonathan;
Willmore, Carlynn;
Scaife, Courtney;
Ward, John

Publication type:

Article

Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1005, doi. 10.1007/s00262-011-1167-3

By:

Castro, Fernanda;
Al-Muftah, Mariam;
Mulryan, Kate;
Jiang, Hui-Rong;
Drijfhout, Jan-Wouter;
Ali, Sumia;
Rutkowski, Andrzej;
Kalaitsidou, Milena;
Gilham, David;
Stern, Peter

Publication type:

Article

An immune-active tumor microenvironment favors clinical response to ipilimumab.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1019, doi. 10.1007/s00262-011-1172-6

By:

Ji, Rui-Ru;
Chasalow, Scott;
Wang, Lisu;
Hamid, Omid;
Schmidt, Henrik;
Cogswell, John;
Alaparthy, Suresh;
Berman, David;
Jure-Kunkel, Maria;
Siemers, Nathan;
Jackson, Jeffrey;
Shahabi, Vafa

Publication type:

Article

Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1045, doi. 10.1007/s00262-011-1174-4

By:

Brudvik, Kristoffer;
Henjum, Karen;
Aandahl, Einar;
Bjørnbeth, Bjørn;
Taskén, Kjetil

Publication type:

Article

Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1033, doi. 10.1007/s00262-011-1176-2

By:

Nuffel, An;
Benteyn, Daphné;
Wilgenhof, Sofie;
Corthals, Jurgen;
Heirman, Carlo;
Neyns, Bart;
Thielemans, Kris;
Bonehill, Aude

Publication type:

Article

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1125, doi. 10.1007/s00262-011-1187-z

By:

Rezvani, Katayoun;
Yong, Agnes;
Mielke, Stephan;
Savani, Bipin;
Jafarpour, Behnam;
Eniafe, Rhoda;
Le, Robert;
Musse, Laura;
Boss, Carole;
Childs, Richard;
John Barrett, A.

Publication type:

Article

Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1065, doi. 10.1007/s00262-011-1165-5

By:

Prado-Garcia, Heriberto;
Romero-Garcia, Susana;
Morales-Fuentes, Jorge;
Aguilar-Cazares, Dolores;
Lopez-Gonzalez, Jose

Publication type:

Article

Collective action of hematopoietic cell subsets mediates anti-IL10R1 and CpG tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1055, doi. 10.1007/s00262-011-1175-3

By:

Chou, Meng-Yun;
Austin, Cary;
Kim, Jeong

Publication type:

Article

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1137, doi. 10.1007/s00262-011-1193-1

By:

McNeel, Douglas;
Smith, Heath;
Eickhoff, Jens;
Lang, Joshua;
Staab, Mary;
Wilding, George;
Liu, Glenn

Publication type:

Article

Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1081, doi. 10.1007/s00262-011-1152-x

By:

Nakashima, Hideyuki;
Miyake, Kotaro;
Clark, Christopher;
Bekisz, Joseph;
Finbloom, Joel;
Husain, Syed;
Baron, Samuel;
Puri, Raj;
Zoon, Kathryn

Publication type:

Article

Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 953, doi. 10.1007/s00262-012-1254-0

By:

Lipowska-Bhalla, Grazyna;
Gilham, David;
Hawkins, Robert;
Rothwell, Dominic

Publication type:

Article

Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1093, doi. 10.1007/s00262-011-1183-3

By:

Mullins, Christina;
Linnebacher, Michael

Publication type:

Article

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1101, doi. 10.1007/s00262-011-1189-x

By:

Tel, Jurjen;
Hato, Stanleyson;
Torensma, Ruurd;
Buschow, Sonja;
Figdor, Carl;
Lesterhuis, W.;
Vries, I.

Publication type:

Article

Harmonization of the intracellular cytokine staining assay.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 967, doi. 10.1007/s00262-012-1282-9

By:

Welters, Marij;
Gouttefangeas, Cécile;
Ramwadhdoebe, Tamara;
Letsch, Anne;
Ottensmeier, Christian;
Britten, Cedrik;
Burg, Sjoerd

Publication type:

Article

Is an immune reaction required for malignant transformation and cancer growth?

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 963, doi. 10.1007/s00262-012-1233-5

By:

Prehn, Richmond;
Prehn, Liisa

Publication type:

Article

Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1149, doi. 10.1007/s00262-012-1267-8

By:

Ziebarth, Angela;
Felder, Mildred;
Harter, Josephine;
Connor, Joseph

Publication type:

Article